Digital Media briefs: October 2012

Share this article:
Digital Media briefs: October 2012
Digital Media briefs: October 2012

The medical social network Doximity has raised $17 million in series B financing, reported MedCity News. CEO Jeff Tangney told the publication the money would be used to “scale the network and expand our offerings.” The company's network provides a secure environment in which professionals can discuss patient cases and exchange patient information. Doximity says 1 in 7 US doctors are in its network.

Eli Lilly released a diabetes app Tuesday that is aimed at educating caregivers. The Lilly Glucagon Mobile App is designed for iPhones and iPads and teaches users how to inject Glucagon into type 1 diabetics as well as provides background information about how Glucagon helps patients manage diabetes. The injection is for severe hypoglycemia.

Healthcare agency and platform developer InTouch Solutions partnered with marketing firm MD Mindset to deliver a joint set of services. Wendy Blackburn, InTouch EVP, told MM&M the collaboration is in its defining stages, but that the relationship will allow the two companies to offer their complementary skill sets to clients in tandem, or to introduce each other's capabilities as client needs arise.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?